IRCT20200105046010N93
Recruiting
未知
Bioequivalence study of Empagliflozin/Metformin12.5/1000 mg ( EMZIP® 12.5/1000 mg) manufactured by Faran pharmed versus originator brand SYNJARDY® 12.5/1000 mg manufactured by ??Boehringer ????? Co in fasting condition in healthy volunteers
Faran Pharmed company0 sites24 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- This study is performed on healthy volunteers and drug concentration in plasma is determined..
- Sponsor
- Faran Pharmed company
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •General Health (Liver, Heart, and Kidney)
- •Body Mass Index (18\-28\)
- •Informed consent
- •Age (18\-55 years old)
Exclusion Criteria
- •History of cardiovascular disease
- •History of liver and kidney disease
- •Alcoholism and Narcoticism
- •History of allergy to Empagliflozin/Metformin
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Bioequivalence study of Empagliflozin Metformin 12.5-1000 mgBioequivalence study of Empagliflozin Metformin 12.5-1000 mg (Tehran Chemie Pharmaceutical Company) versus Synjiardy(Boehringer Ingelheim) Tablet after single oral dosing in healthy volunteers.IRCT20220111053692N17Tehran Chemie Pharmaceutical Company24
Recruiting
Not Applicable
Investigating the in vivo bioequivalence of Empagliflozin /Metformin tabletIRCT20210519051345N31Tabriz University of Medical Sciences24
Completed
Phase 1
Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate TabletsHealthyNCT02028767Boehringer Ingelheim32
Completed
Phase 1
Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered TogetherHealthyNCT01811953Boehringer Ingelheim48
Completed
Not Applicable
Comparative in vivo evaluation of 2 Empagliflozin 12.5 Combined Tablet with Metformin 1000 mg Tablet formulations.IRCT20180620040164N52Darou darman Pars Co.24